Health Condition 1: I10- Essential (primary) hypertension
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffering from essential hypertension prehypertensives SBP 120 to 139 mmHg DBP 80 to 89 mmHg, Stage 1 hypertensives SBP 140 to 159 mmHg DBP 90 to 99 mmHg and Stage 2 hypertensives SBP more than 160 mmHg DBP more than100 mmHg Aged 30 to 80 years Both sexes Whose history examination and routine investigations revealed no evidence of obvious secondary causes Given written informed consent
Exclusion criteria
Exclusion criteria: Diagnosis or findings from the history were Uncertain Physical examination or routine investigations produced the suspicion of a secondary cause for hypertension The cases were diagnosed provisional Or confirmatory cases of secondary hypertension The cases of malignant hypertension SBP More than 200 mmHg and DBP More than 140 mmHg Patients were suffering from isolated systolic hypertension SBP More than 140 mmHg and or DBP less than 90 mmHg as was mostly found in elderly patients Immunocompromised patients Diagnosed cases of developmental defects or congenital abnormalities Pregnant women women who are breast feeding and or with likelihood of pregnancy Patients with a history of drug alcohol abuse Cases who refuse to give the consent for the study The cases which require emergency care or rescue treatment All the cases including the complications of hypertension that is cases of hypertensive nephropathy hypertensive retinopathy stroke CAD LVH will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| According to the pre and post changes in value of systolic and diastolic blood pressureTimepoint: pre changes in value of systolic and diastolic blood pressurewill be taken at baseline of treatment and post changes in value of systolic and diastolic blood pressure will be taken at the end of study that is 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The study is expected to show effectiveness of homoeopathic medicines selected on the basis of totality of symptoms in cases of essential hypertensionTimepoint: 12 months;The study is expected to show effectiveness of preidentified homoeopathic medicine Amylenum Nitrosum in cases of essential hypertensionTimepoint: 12 months;The study will help to compare the effectiveness of homoeopathic medicines selected on the basis of totality of symptoms and preidentified homoeopathic medicine Amylenum Nitrosum in cases of essential hypertensionTimepoint: 12 months | — |
Countries
India
Contacts
Dr M P K Homoeopathic Medical College Hospital And Research Centre